<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02063646</url>
  </required_header>
  <id_info>
    <org_study_id>INAF-2012-242</org_study_id>
    <nct_id>NCT02063646</nct_id>
  </id_info>
  <brief_title>Effect of a Polyphenol-rich Food Supplement on Cognitive Function in Healthy Aging Adults</brief_title>
  <acronym>Neurophenol</acronym>
  <official_title>Effect of a Polyphenol-rich Food Supplement on Cognitive Function in Healthy Aging Adults: Randomized, Placebo-controlled, Double-blind Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Neurophenols Consortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Activ'inside</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Atrium Innovations</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fruit d'Or</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laboratoire NutriNeuro Université de Bordeaux/INRA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NutraCanada</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Neurophenols Consortium</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several preliminary studies have shown that diet can have beneficial effects on cognitive
      decline. Among food shown to have such effects are some polyphenols from selected botanicals.

      Preclinical studies have concluded that polyphenols play a role in moderation of oxidative
      stress and inflammation, increased neuronal signaling, and improved metabolic function among
      other effects. Noteworthy, a positive and statistically significant association between the
      midlife level of polyphenol intake and cognitive function assessed 13 years later was found
      in a cohort of 2574 adults.

      Several mechanisms may be involved in these positive effects of food polyphenols on cognitive
      function in older adults: experimental studies suggest that polyphenols display
      neuroprotective effects, enhancement of the neuronal function, stimulation of brain flow and
      inducing neurogenesis, and might prevent age-related damage to the central nervous system
      through their antioxidant and anti-inflammatory activities.

      Based on these promising results, a food supplement from botanicals offering complementary
      polyphenol profile was developed. This food supplement is aimed to aid at maintenance of
      cognitive function in older adults.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project aims to investigate the effects of 6 months supplementation with a
      polyphenol-rich supplement vs. placebo to consume daily on human cognitive function.
      Polyphenol-rich supplement and placebo will be provided as capsules matched for appearance.

      The study will be conducted as a randomized, double-blind, parallel-groups (2 arms)
      placebo-controlled, multicentre interventional design. Two groups, each of 102 volunteers,
      are studied. One group of volunteers will consume the polyphenol-rich product while the other
      one will consume the placebo product.

      Each volunteer will be seen for 3 visits at the investigational site, will have 2 follow-up
      calls and mid-term dietary survey. Baseline and follow-up visit will include cognitive
      assessment with the CANTAB battery. CANTAB tests will cover several aspects of memory:
      visio-spatial learning and episodic memory, verbal recognition memory and visio-spatial
      working memory. Moreover, psychological and mood components will be evaluated (mnesic
      complaint, depression, fatigue). Physical activity and food habits will also be recorded.
      Finally, biological parameters will be assessed (lipid profile, glycemia, insulinemia, CRPus,
      thyroid stimulating hormone, transthyretin, plasma level of phenolic compounds).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CANTAB - Paired Associate Learning test (PAL)</measure>
    <time_frame>24 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>CANTAB - Verbal Recognition Memory (VRM)</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CANTAB - Spatial Span test (SSP)</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CANTAB - Reverse Spatial Span test (Reverse SSP)</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wechsler Memory Scale - Logical memory subtest</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>McNair scale</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Geriatric Depression Scale</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini-Mental State Examination</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Multidimensional Fatigue Inventory (MFI-20)</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Lipid profile</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Insulinemia and glycemia</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Inflammatory markers</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Hormones</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Urinary polyphenols</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Fatty acid profile in erythrocyte membranes</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Retinol Binding Protein and Transtyretin</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Nuclear receptor expression in mononuclear cells</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Gene expression in mononuclear cells by microarray approach</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Epigenetic markers</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">204</enrollment>
  <condition>Healthy Elderly</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The placebo is a capsule with same appearance and organoleptic properties as the active product, containing no active component.
Dose: 2 capsules per day, one capsule at least 1 hour after breakfast and one capsule at least one hour after dinner, with a glass of water.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Polyphenol-rich extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The test product is a food supplement named Neurophenol. It is presented as a hard-shell capsule containing polyphenol-rich extracts.
Dose: 2 capsules per day, one capsule at least 1 hour after breakfast and one capsule at least one hour after dinner, with a glass of water.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Polyphenol-rich extract</intervention_name>
    <description>Two groups, each of 102 volunteers, are studied. For 24 weeks, one group of volunteers will consume the active product (polyphenol-rich extract) while the other one will consume the placebo product.</description>
    <arm_group_label>Polyphenol-rich extract</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The placebo is a capsule with same appearance and organoleptic properties as the active product, containing no active component.
Two groups, each of 102 volunteers, are studied. For 24 weeks, one group of volunteers will consume the active product (polyphenol-rich extract) while the other one will consume the placebo product.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Independent subjects, living at home;

          -  Body Mass Index (BMI) 20-30 kg/m2 (limits included);

          -  26 &lt; MMSE score ≤ 29

          -  Logical memory subtest of the Wechsler Memory Scale (16-69 years battery) sub-scores
             complying with the following:

               -  Immediate recall score &lt; 29;

               -  Delayed recall score &lt; 16;

        Exclusion Criteria:

          -  Evidence of actual major depressive disorder according to the module A of the Mini
             International Neuropsychiatric Interview (MINI);

          -  Subject consuming food supplements likely to have an effect on memory;

          -  High physical activity practice;

          -  Restrictive or unbalanced diet (hypocaloric, vegetarian, vegan, …) self-declared at
             V0;

          -  Diabetes;

          -  Cardiovascular disease diagnosed within less than 2 years, with the following
             exceptions: subjects with controlled (medicated) high blood pressure and/ or
             controlled (medicated) can be included;

          -  Personal history of Cerebrovascular Accident (CVA);

          -  Unbalanced thyroid disease;

          -  Anti-depressant treatment stopped since less than 3 months or still ongoing;

          -  Personal history of schizophrenia or other psychiatric disorders;

          -  Ongoing neuroleptic treatment;

          -  Uncorrected visual or auditory dysfunction (according to the volunteer's
             self-declaration);

          -  History of moderate to severe traumatic brain injury and / or intracranial surgery;

          -  Life threatening pathology (such as cancer) in remission for less than 1 year or still
             ongoing;

          -  General anesthesia in the last 6 months or planned in the next 6 months;

          -  Documented food allergy(ies), namely to one of the components of the study product;

          -  Psychological or linguistic incapability to sign the informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carol Hudon, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Véronique Pallet, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laboratoire NutriNeuro Université de Bordeaux/INRA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Catherine Bégin, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>INAF (Institute of nutrition and functionnal foods)</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 0A6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Biofortis</name>
      <address>
        <city>Saint-Herblain</city>
        <zip>44800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.neurophenols.org</url>
    <description>Click this link for more information about this study</description>
  </link>
  <link>
    <url>http://www6.bordeaux-aquitaine.inra.fr/nutrineuro</url>
    <description>Laboratoire NutriNeuro INRA-Université de Bordeaux</description>
  </link>
  <reference>
    <citation>Krikorian R, Boespflug EL, Fleck DE, Stein AL, Wightman JD, Shidler MD, Sadat-Hossieny S. Concord grape juice supplementation and neurocognitive function in human aging. J Agric Food Chem. 2012 Jun 13;60(23):5736-42. doi: 10.1021/jf300277g. Epub 2012 Apr 9.</citation>
    <PMID>22468945</PMID>
  </reference>
  <reference>
    <citation>Kesse-Guyot E, Fezeu L, Andreeva VA, Touvier M, Scalbert A, Hercberg S, Galan P. Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later. J Nutr. 2012 Jan;142(1):76-83. doi: 10.3945/jn.111.144428. Epub 2011 Nov 16.</citation>
    <PMID>22090468</PMID>
  </reference>
  <reference>
    <citation>Rossi L, Mazzitelli S, Arciello M, Capo CR, Rotilio G. Benefits from dietary polyphenols for brain aging and Alzheimer's disease. Neurochem Res. 2008 Dec;33(12):2390-400. doi: 10.1007/s11064-008-9696-7. Epub 2008 Apr 16. Review.</citation>
    <PMID>18415677</PMID>
  </reference>
  <reference>
    <citation>Spencer JP, Vauzour D, Rendeiro C. Flavonoids and cognition: the molecular mechanisms underlying their behavioural effects. Arch Biochem Biophys. 2009 Dec;492(1-2):1-9. doi: 10.1016/j.abb.2009.10.003. Epub 2009 Oct 12. Review.</citation>
    <PMID>19822127</PMID>
  </reference>
  <reference>
    <citation>Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JP. The neuroprotective potential of flavonoids: a multiplicity of effects. Genes Nutr. 2008 Dec;3(3-4):115-26. doi: 10.1007/s12263-008-0091-4.</citation>
    <PMID>18937002</PMID>
  </reference>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2014</study_first_submitted>
  <study_first_submitted_qc>February 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 14, 2014</study_first_posted>
  <last_update_submitted>May 25, 2015</last_update_submitted>
  <last_update_submitted_qc>May 25, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>polyphenols</keyword>
  <keyword>memory</keyword>
  <keyword>elderly</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

